Just in time for allergy season, a recent FDA warning describes a new side effect for those who take Zyrtec or Xyzal ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis ...

London: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ...

US FDA accepts for review GSK’s NDA for linerixibat to treat cholestatic pruritus in patients with PBC: London, UK Tuesday, June 3, 2025, 11:00 Hrs [IST] GSK plc announced the U ...

Although the side effect is rare, the FDA said some patients experienced severe itching that required medical attention.

A diet trial becomes reasonable when pruritus is persistent and nonseasonal or when standard atopy treatments fail over ...

Some patients may suffer from unbearable itching across their entire body after stopping common allergy medications, health ...

The two antihistamines are approved for seasonal allergic rhinitis in individuals 2 years and up, along with perennial ...

The agency will require manufacturers to add a warning to prescription and OTC labeling about the risk of itching and the ...

CHICAGO -- For the first time in a phase III trial, overall survival (OS) in unresectable pancreatic cancer improved ...

Two common anti-allergy medications can leave you feeling scratchier than ever. The Food and Drug Administration is warning ...